Stem cell promises gets ahead of science

09/12/2013 | New York Times (tiered subscription model), The

Numerous clinics offer stem cell treatments for conditions such as lung disease and spinal cord injuries, but scientists have proven neither the efficacy nor safety of these treatments. Stem cell scientists worry that the marketing of unproven, unregulated products and treatments will undermine the legitimacy of their research. A statement from the International Society for Stem Cell Research says the nonscientific use of stem cells represents "a threat to patient welfare, patient autonomy and to the scientific process."

View Full Article in:

New York Times (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY